BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18209868)

  • 1. [Pseudo-Cushing states].
    Romanholi DJ; Salgado LR
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1303-13. PubMed ID: 18209868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis].
    Ceroni L; Cota D; Pasquali R
    Minerva Endocrinol; 2000 Jun; 25(2):47-54. PubMed ID: 11189791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
    Chabre O
    Ann Endocrinol (Paris); 2018 Jun; 79(3):138-145. PubMed ID: 29716734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
    Gold PW; Loriaux DL; Roy A; Kling MA; Calabrese JR; Kellner CH; Nieman LK; Post RM; Pickar D; Gallucci W
    N Engl J Med; 1986 May; 314(21):1329-35. PubMed ID: 3010108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful effects of functional hypercortisolism: a working hypothesis.
    Tirabassi G; Boscaro M; Arnaldi G
    Endocrine; 2014 Aug; 46(3):370-86. PubMed ID: 24282037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of corticotropin-releasing hormone in the inferior petrosal sinuses of healthy volunteers, patients with Cushing's syndrome, and patients with pseudo-Cushing states.
    Yanovski JA; Nieman LK; Doppman JL; Chrousos GP; Wilder RL; Gold PW; Kalogeras KT
    J Clin Endocrinol Metab; 1998 May; 83(5):1485-8. PubMed ID: 9589643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).
    Findling JW; Raff H
    Eur J Endocrinol; 2017 May; 176(5):R205-R216. PubMed ID: 28179447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic tests for Cushing's syndrome.
    Nieman LK
    Ann N Y Acad Sci; 2002 Sep; 970():112-8. PubMed ID: 12381546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-Cushing's syndrome: the role of alcohol.
    Elias AN; Meshkinpour H; Valenta LJ; Grossman MK
    J Clin Gastroenterol; 1982 Apr; 4(2):137-9. PubMed ID: 6282953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse.
    Besemer F; Pereira AM; Smit JW
    Neth J Med; 2011; 69(7):318-23. PubMed ID: 21934176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in the diagnosis and management of Cushing's syndrome.
    Bansal V; El Asmar N; Selman WR; Arafah BM
    Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PseudoCushing: why a clinical challenge?
    Pecori Giraldi F
    J Endocrinol Invest; 2015 Oct; 38(10):1137-9. PubMed ID: 25916434
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and differential diagnosis of Cushing's syndrome].
    Penezić Z; Zarković M; Vujović S; Drezgić M
    Srp Arh Celok Lek; 2006; 134(11-12):558-66. PubMed ID: 17304774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in the diagnosis of Cushing's syndrome.
    Vilar L; Freitas Mda C; Faria M; Montenegro R; Casulari LA; Naves L; Bruno OD
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1207-16. PubMed ID: 18209858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.
    Cunningham JM; Buxton OM; Weiss RE
    J Endocrinol Invest; 2002 Oct; 25(9):791-9. PubMed ID: 12398238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone: from endocrinology to psychobiology.
    Smith MA; Kling MA; Whitfield HJ; Brandt HA; Demitrack MA; Geracioti TD; Chrousos GP; Gold PW
    Horm Res; 1989; 31(1-2):66-71. PubMed ID: 2656470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.